These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6531442)

  • 21. Dopamine metabolites in rat cisternal cerebrospinal fluid: major contribution from extrastriatal dopamine neurones.
    Hutson PH; Curzon G
    J Neurochem; 1986 Jan; 46(1):186-90. PubMed ID: 2415677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
    Broch OJ
    Eur J Pharmacol; 1976 Sep; 39(1):33-40. PubMed ID: 964303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A kinetic analysis of the effects of beta-phenylethylamine on the concentrations of dopamine and its metabolites in the rat striatum.
    Sato S; Tamura A; Kitagawa S; Koshiro A
    J Pharm Sci; 1997 Apr; 86(4):487-96. PubMed ID: 9109054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A; Nissbrandt H
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of 3,4-dihydroxyphenylacetic acid and 3-methoxytyramine specific activity rat striatum.
    Di Giulio AM; Groppetti A; Algeri S; Ponzio F; Cattabeni F; Galli CL
    Anal Biochem; 1979 Jan; 92(1):82-90. PubMed ID: 426290
    [No Abstract]   [Full Text] [Related]  

  • 26. Does acute L-DOPA increase active release of dopamine from dopaminergic neurons?
    Ponzio F; Achilli G; Perego C; Rinaldi G; Algeri S
    Brain Res; 1983 Aug; 273(1):45-51. PubMed ID: 6616231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.
    Kito S; Shimoyama M; Arakawa R
    Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake and release of meta-tyramine, para-tyramine, and dopamine in rat striatal slices.
    Dyck LE
    Neurochem Res; 1978 Dec; 3(6):775-91. PubMed ID: 740128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenylalanine administration influences dopamine release in the rat's corpus striatum.
    During MJ; Acworth IN; Wurtman RJ
    Neurosci Lett; 1988 Oct; 93(1):91-5. PubMed ID: 3211373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine metabolites in human brain.
    Wilk S; Stanley M
    Psychopharmacology (Berl); 1978 Apr; 57(1):77-81. PubMed ID: 96472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats.
    Chen YF; Oparil S
    Brain Res; 1987 Jan; 400(2):225-31. PubMed ID: 2949797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography--electrochemical detection system.
    Magnusson O; Nilsson LB; Westerlund D
    J Chromatogr; 1980 Dec; 221(2):237-47. PubMed ID: 7217293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum.
    Pileblad E; Fornstedt B; Clark D; Carlsson A
    J Pharm Pharmacol; 1985 Oct; 37(10):707-11. PubMed ID: 2416901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of sufentanil on the release and metabolism of dopamine and ascorbic acid and glutamate release in the striatum of freely moving rats.
    Serra PA; Susini G; Rocchitta G; Migheli R; Dessanti G; Miele E; Desole MS; Miele M
    Neurosci Lett; 2003 Jun; 344(1):9-12. PubMed ID: 12781909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal 3-methoxytyramine as an index of dopamine release effects of electrical stimulation.
    Wood PL; Nair NP; Bozarth M
    Neurosci Lett; 1982 Oct; 32(3):291-4. PubMed ID: 6294566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat.
    Juorio AV
    Br J Pharmacol; 1980 Nov; 70(3):475-80. PubMed ID: 6777007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons.
    Di Giulio AM; Groppetti A; Cattabeni F; Galli CL; Maggi A; Algeri S; Ponzio F
    Eur J Pharmacol; 1978 Nov; 52(2):201-7. PubMed ID: 729633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine.
    Bailey BA; Philips SR; Boulton AA
    Neurochem Res; 1987 Feb; 12(2):173-8. PubMed ID: 2437473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.
    De Klippel N; Sarre S; Ebinger G; Michotte Y
    Brain Res; 1993 Dec; 630(1-2):57-64. PubMed ID: 8118706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.